chr3-43079687-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_032806.6(POMGNT2):c.*2G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00211 in 1,608,040 control chromosomes in the GnomAD database, including 75 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 42 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 33 hom. )
Consequence
POMGNT2
NM_032806.6 3_prime_UTR
NM_032806.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.48
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 3-43079687-C-T is Benign according to our data. Variant chr3-43079687-C-T is described in ClinVar as [Benign]. Clinvar id is 385243.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0109 (1658/152332) while in subpopulation AFR AF= 0.0375 (1559/41574). AF 95% confidence interval is 0.036. There are 42 homozygotes in gnomad4. There are 790 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 42 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
POMGNT2 | NM_032806.6 | c.*2G>A | 3_prime_UTR_variant | 2/2 | ENST00000344697.3 | ||
POMGNT2 | XM_005265515.4 | c.*2G>A | 3_prime_UTR_variant | 3/3 | |||
POMGNT2 | XM_011534163.3 | c.*2G>A | 3_prime_UTR_variant | 3/3 | |||
POMGNT2 | XM_017007353.2 | c.*2G>A | 3_prime_UTR_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
POMGNT2 | ENST00000344697.3 | c.*2G>A | 3_prime_UTR_variant | 2/2 | 1 | NM_032806.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0109 AC: 1654AN: 152214Hom.: 41 Cov.: 33
GnomAD3 genomes
AF:
AC:
1654
AN:
152214
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00311 AC: 767AN: 246286Hom.: 19 AF XY: 0.00220 AC XY: 293AN XY: 132908
GnomAD3 exomes
AF:
AC:
767
AN:
246286
Hom.:
AF XY:
AC XY:
293
AN XY:
132908
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00119 AC: 1733AN: 1455708Hom.: 33 Cov.: 29 AF XY: 0.00103 AC XY: 747AN XY: 723552
GnomAD4 exome
AF:
AC:
1733
AN:
1455708
Hom.:
Cov.:
29
AF XY:
AC XY:
747
AN XY:
723552
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0109 AC: 1658AN: 152332Hom.: 42 Cov.: 33 AF XY: 0.0106 AC XY: 790AN XY: 74488
GnomAD4 genome
AF:
AC:
1658
AN:
152332
Hom.:
Cov.:
33
AF XY:
AC XY:
790
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 05, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at